Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.87M Buy
430,156
+70,360
+20% +$646K ﹤0.01% 1735
2026
Q1
$3.34M Sell
359,796
-8,196
-2% -$80.7K ﹤0.01% 1779
2025
Q4
$2.57M Buy
367,992
+20,729
+6% +$130K ﹤0.01% 1781
2025
Q3
$1.98M Sell
347,263
-344,390
-50% -$1.84M ﹤0.01% 1753
2025
Q2
$3.31M Buy
691,653
+217,376
+46% +$1.25M ﹤0.01% 1909
2025
Q1
$4.11M Sell
474,277
-75,362
-14% -$790K ﹤0.01% 1665
2024
Q4
$6.67M Buy
549,639
+43,621
+9% +$610K ﹤0.01% 1460
2024
Q3
$8.51M Sell
506,018
-80,594
-14% -$1.33M ﹤0.01% 1310
2024
Q2
$9.17M Buy
586,612
+341,724
+140% +$4.75M ﹤0.01% 1175
2024
Q1
$3.86M Sell
244,888
-2,843
-1% -$47.6K ﹤0.01% 1369
2023
Q4
$4.98M Hold
247,731
﹤0.01% 1244
2023
Q3
$4.59M Buy
247,731
+4,725
+2% +$103K ﹤0.01% 1241
2023
Q2
$4.5M Hold
243,006
﹤0.01% 1280
2023
Q1
$4.5M Buy
+243,006
New +$4.57M ﹤0.01% 1280
2022
Q4
Sell
-187,758
Closed -$2.62M 2689
2022
Q3
$2.62M Buy
187,758
+53,625
+40% +$1.08M ﹤0.01% 1458
2022
Q2
$3.23M Sell
134,133
-4,280
-3% -$115K ﹤0.01% 1397
2022
Q1
$4.27M Buy
138,413
+10,795
+8% +$388K ﹤0.01% 1428
2021
Q4
$5.8M Sell
127,618
-2,382
-2% -$102K ﹤0.01% 1355
2021
Q3
$5.65M Buy
130,000
+2,281
+2% +$99.2K ﹤0.01% 1304
2021
Q2
$5.88M Buy
127,719
+2,911
+2% +$135K ﹤0.01% 1298
2021
Q1
$5.55M Buy
124,808
+2,852
+2% +$120K ﹤0.01% 1293
2020
Q4
$4.84M Buy
121,956
+2,374
+2% +$88.2K ﹤0.01% 1310
2020
Q3
$4.68M Buy
119,582
+7,530
+7% +$288K ﹤0.01% 1178
2020
Q2
$4.35M Sell
112,052
-358
-0.3% -$12.1K ﹤0.01% 1172
2020
Q1
$3.77M Sell
112,410
-176
-0.2% -$5.78K ﹤0.01% 1158
2019
Q4
$3.67M Buy
112,586
+7,688
+7% +$253K ﹤0.01% 1328
2019
Q3
$3.57M Buy
104,898
+14,420
+16% +$499K ﹤0.01% 1346
2019
Q2
$2.81M Buy
90,478
+7,044
+8% +$208K ﹤0.01% 1425
2019
Q1
$2.39M Buy
83,434
+10,036
+14% +$304K ﹤0.01% 1433
2018
Q4
$2.09M Buy
73,398
+3,304
+5% +$103K ﹤0.01% 1414
2018
Q3
$2.51M Buy
70,094
+1,052
+2% +$44.8K ﹤0.01% 1411
2018
Q2
$2.77M Sell
69,042
-2,832
-4% -$104K ﹤0.01% 1373
2018
Q1
$2.41M Buy
71,874
+8,685
+14% +$262K ﹤0.01% 1392
2017
Q4
$1.95M Buy
63,189
+1,008
+2% +$30.5K ﹤0.01% 1447
2017
Q3
$1.81M Buy
62,181
+4,464
+8% +$115K ﹤0.01% 1447
2017
Q2
$1.5M Buy
57,717
+2,149
+4% +$51.4K ﹤0.01% 1483
2017
Q1
$1.37M Buy
55,568
+8,880
+19% +$217K ﹤0.01% 1504
2016
Q4
$1.16M Sell
46,688
-17,277
-27% -$384K ﹤0.01% 1500
2016
Q3
$1.34M Hold
63,965
﹤0.01% 1545
2016
Q2
$1.35M Buy
63,965
+3,269
+5% +$60.9K ﹤0.01% 1512
2016
Q1
$1.15M Sell
60,696
-15,803
-21% -$301K ﹤0.01% 1580
2015
Q4
$1.62M Buy
76,499
+11,899
+18% +$243K ﹤0.01% 1538
2015
Q3
$1.09M Buy
64,600
+14,475
+29% +$285K ﹤0.01% 1689
2015
Q2
$892K Buy
50,125
+5,330
+12% +$92.3K ﹤0.01% 1729
2015
Q1
$785K Buy
44,795
+1,600
+4% +$29.3K ﹤0.01% 1738
2014
Q4
$803K Hold
43,195
﹤0.01% 1689
2014
Q3
$640K Hold
43,195
﹤0.01% 1741
2014
Q2
$656K Buy
43,195
+2,400
+6% +$35.7K ﹤0.01% 1759
2014
Q1
$688K Buy
40,795
+7,734
+23% +$126K ﹤0.01% 1702
2013
Q4
$567K Buy
33,061
+3,865
+13% +$67.2K ﹤0.01% 1746
2013
Q3
$443K Hold
29,196
﹤0.01% 1846
2013
Q2
$406K Buy
+29,196
New +$385K ﹤0.01% 1802

Other funds holding NEOG

UBS AM's NEOG Position: Q2 2026 in Review

UBS AM increased its Neogen (NEOG) stake by 20% in Q2 2026, buying an estimated $646K and bringing the position to 430,156 shares worth $3.87M. The position accounts for ﹤0.01% of the portfolio, ranked #1735.

UBS AM first reported a position in NEOG in Q2 2013 and has held it in 52 quarters since. The position peaked at $9.17M in Q2 2024. 316 funds tracked by Wall St. Rank hold NEOG as of Q2 2026.

  • UBS AM held 430,156 shares of Neogen worth $3.87M as of Q2 2026.
  • UBS AM bought 70,360 Neogen shares in Q2 2026, an estimated $646K.
  • Neogen made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #1735 holding.
  • UBS AM first reported a position in Neogen in Q2 2013 and has held it in 52 quarters since.
  • UBS AM's Neogen position peaked at $9.17M in Q2 2024.
  • 316 funds tracked by Wall St. Rank held Neogen as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.